|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.95 USD | +1.56% |
|
-1.52% | -1.52% |
| May. 09 | Transcript : ProQR Therapeutics N.V. - Special Call | |
| May. 09 | ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ProQR Therapeutics N.V. at the annual general meeting of shareholders on June 30, 2022, approved the appointment of Management Board member Rene Beukema.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.52% | 156M | |
| +8.84% | 114B | |
| +11.43% | 104B | |
| -12.65% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -3.02% | 17.89B | |
| +7.93% | 14.28B | |
| +35.40% | 12.55B |
PROQR THERAPEUTICS N.V. 
